Search research articles
Contact Us
Filters
Showing results (101-110 of 116) with videos related to
Page
of 12
Sort By:
British Journal of Cancer
|
October 16, 2018
Galunisertib plus gemcitabine vs. gemcitabine for first-line treatment of patients with unresectable pancreatic cancer
Davide Melisi, Rocio Garcia-Carbonero, Teresa Macarulla, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 22, 2006
Randomized phase III trial of gemcitabine plus cisplatin compared with gemcitabine alone in advanced pancreatic cancer
Volker Heinemann, Detlef Quietzsch, Frank Gieseler, et al.
Colorectal Disease : the Official Journal of the Association of Coloproctology of Great Britain and Ireland
|
February 7, 2023
The other colon cancer: a population-based cohort study of appendix tumour trends and prognosis
Kathrin Halfter, Gabriele Schubert-Fritschle, Frederick Klauschen, et al.
Cancer Chemotherapy and Pharmacology
|
March 20, 2019
TGFβ receptor inhibitor galunisertib is linked to inflammation- and remodeling-related proteins in patients with pancreatic cancer
Davide Melisi, Rocio Garcia-Carbonero, Teresa Macarulla, et al.
European Journal of Cancer (Oxford, England : 1990)
|
August 15, 2022
FOLFOX plus panitumumab or FOLFOX alone as additive therapy following R0/1 resection of RAS wild-type colorectal cancer liver metastases - The PARLIM trial (AIO KRK 0314)
Dominik Paul Modest, Meinolf Karthaus, Stefan Kasper, et al.
European Journal of Cancer (Oxford, England : 1990)
|
November 15, 2025
First-line treatment efficacy of anti-EGFR versus anti-VEGF antibodies in BRAF<sup>V600E</sup>-mutated metastatic colorectal cancer according to primary tumor sidedness: A pooled analysis of seven clinical trials performed in the first-line treatment of mCRC (German AIO Study Group)
Lena Weiss, Sebastian Stintzing, Dominik Paul Modest, et al.
The Lancet. Gastroenterology & Hepatology
|
December 18, 2020
Nab-paclitaxel plus gemcitabine versus nab-paclitaxel plus gemcitabine followed by FOLFIRINOX induction chemotherapy in locally advanced pancreatic cancer (NEOLAP-AIO-PAK-0113): a multicentre, randomised, phase 2 trial
Volker Kunzmann, Jens T Siveke, Hana Algül, et al.
Journal of Clinical Microbiology
|
April 12, 2012
Multicenter evaluation of the Staphylococcus QuickFISH method for simultaneous identification of Staphylococcus aureus and coagulase-negative staphylococci directly from blood culture bottles in less than 30 minutes
Melissa K Deck, Erica S Anderson, Rebecca J Buckner, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
November 11, 2011
The impact of 18F-FDG PET on the management of patients with suspected large vessel vasculitis
Martin Fuchs, Matthias Briel, Thomas Daikeler, et al.
Diagnostic Microbiology and Infectious Disease
|
January 21, 2014
Rapid detection of Enterococcus spp. direct from blood culture bottles using Enterococcus QuickFISH method: a multicenter investigation
Melissa K Deck, Erica S Anderson, Rebecca J Buckner, et al.
Page
of 12
Search research articles
Search
Showing results (101-110 of 116) with videos related to
Sort By:
Page
of 12
British Journal of Cancer
|
October 16, 2018
Galunisertib plus gemcitabine vs. gemcitabine for first-line treatment of patients with unresectable pancreatic cancer
Davide Melisi, Rocio Garcia-Carbonero, Teresa Macarulla, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 22, 2006
Randomized phase III trial of gemcitabine plus cisplatin compared with gemcitabine alone in advanced pancreatic cancer
Volker Heinemann, Detlef Quietzsch, Frank Gieseler, et al.
Colorectal Disease : the Official Journal of the Association of Coloproctology of Great Britain and Ireland
|
February 7, 2023
The other colon cancer: a population-based cohort study of appendix tumour trends and prognosis
Kathrin Halfter, Gabriele Schubert-Fritschle, Frederick Klauschen, et al.
Cancer Chemotherapy and Pharmacology
|
March 20, 2019
TGFβ receptor inhibitor galunisertib is linked to inflammation- and remodeling-related proteins in patients with pancreatic cancer
Davide Melisi, Rocio Garcia-Carbonero, Teresa Macarulla, et al.
European Journal of Cancer (Oxford, England : 1990)
|
August 15, 2022
FOLFOX plus panitumumab or FOLFOX alone as additive therapy following R0/1 resection of RAS wild-type colorectal cancer liver metastases - The PARLIM trial (AIO KRK 0314)
Dominik Paul Modest, Meinolf Karthaus, Stefan Kasper, et al.
European Journal of Cancer (Oxford, England : 1990)
|
November 15, 2025
First-line treatment efficacy of anti-EGFR versus anti-VEGF antibodies in BRAF<sup>V600E</sup>-mutated metastatic colorectal cancer according to primary tumor sidedness: A pooled analysis of seven clinical trials performed in the first-line treatment of mCRC (German AIO Study Group)
Lena Weiss, Sebastian Stintzing, Dominik Paul Modest, et al.
The Lancet. Gastroenterology & Hepatology
|
December 18, 2020
Nab-paclitaxel plus gemcitabine versus nab-paclitaxel plus gemcitabine followed by FOLFIRINOX induction chemotherapy in locally advanced pancreatic cancer (NEOLAP-AIO-PAK-0113): a multicentre, randomised, phase 2 trial
Volker Kunzmann, Jens T Siveke, Hana Algül, et al.
Journal of Clinical Microbiology
|
April 12, 2012
Multicenter evaluation of the Staphylococcus QuickFISH method for simultaneous identification of Staphylococcus aureus and coagulase-negative staphylococci directly from blood culture bottles in less than 30 minutes
Melissa K Deck, Erica S Anderson, Rebecca J Buckner, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
November 11, 2011
The impact of 18F-FDG PET on the management of patients with suspected large vessel vasculitis
Martin Fuchs, Matthias Briel, Thomas Daikeler, et al.
Diagnostic Microbiology and Infectious Disease
|
January 21, 2014
Rapid detection of Enterococcus spp. direct from blood culture bottles using Enterococcus QuickFISH method: a multicenter investigation
Melissa K Deck, Erica S Anderson, Rebecca J Buckner, et al.
Page
of 12